Skip Navigation

VAERS Bibliography - October 2002

  1. Progress Toward Poliomyelitis Eradication--Angola, January 1998-June 2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 762-764. 
  2. Immunization Registry Progress--United States, 2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 760-762. 
  3. Outbreak of Measles--Venezuela and Colombia, 2001-2002 MMWR Morb.Mortal.Wkly.Rep.  8-30-2002, 51 (34): 757-760. 
  4. Ahmad, K.  Vaccination With Varicella Protects Against Zoster Infection Lancet Oncol.  2002, 3 (9): 523. 
  5. Arthur, A. J., Matthews, R. J., Jagger, C., Clarke, M., Hipkin, A., and Bennison, D. P.  Improving Uptake of Influenza Vaccination Among Older People: a Randomised Controlled Trial Br.J.Gen.Pract.  2002, 52 (482): 717-2. 
  6. Buschard, K. and Funda, D.  Vaccination Studies in Type 1 Diabetes Lancet  8-10-2002, 360 (9331): 488. 
  7. Carabin, H., John, Edmunds W., Kou, U., Van Den, Hof S., and Hung, Nguyen, V  The Average Cost of Measles Cases and Adverse Events Following Vaccination in Industrialised Countries BMC.Public Health  2002, 19;2 (1): 22. 
  8. Chen, M., Hu, K. F., Rozell, B., Orvell, C., Morein, B., and Liljestrom, P.  Vaccination With Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus J.Immunol.  9-15-2002, 169 (6): 3208-3216. 
  9. Choudhri, Y., Walop, W., Squires, S., Tam, T., King, A., Skowronski, D., Warrington, R., and Wood, J.  ORS During the 2000-2001 Influenza Vaccination Season Can.Commun.Dis.Rep.  9-1-2002, 28:2-8: 2-8. 
  10. Eichner, M., Diebner, H. H., Schubert, C., Kreth, H. W., and Dietz, K.   Estimation of the Time-Dependent Vaccine Efficacy From a Measles Epidemic Stat.Med.  8-30-2002, 21 (16): 2355-2368. 
  11. Engler, R. J., Kenner, J., and Leung, D. Y.  Smallpox Vaccination: Risk Considerations for Patients With Atopic Dermatitis J.Allergy Clin.Immunol.  2002, 110 (3): 357-365. 
  12. Hopkins, Tanne J.  Old Smallpox Vaccination May Still Protect BMJ  9-7-2002, 325 (7363): 513. 
  13. Huo, Z., Miles, J., Harris, T., and Riches, P.  Effect of Pneumovax((R)) II Vaccination in High-Risk Individuals on Specific Antibody and Opsonic Capacity Against Specific and Non-Specific Antigen Vaccine  10-4-2002, 20 (29-30): 3532. 
  14. Husain, S., Slobodkin, D., and Weinstein, R. A.  Pneumococcal Vaccination: Analysis of Opportunities in an Inner-City Hospital Arch.Intern.Med.  9-23-2002, 162 (17): 1961-1965. 
  15. Jackson, L. A., Yu, O., Heckbert, S. R., Slobodkin, D., and Weinstein, B. M., Malais, D., Barlow, W. E., and Thompson, W. W.  Influenza Vaccination Is Not Associated With a Reduction in the Risk of Recurrent Coronary Events Am.J.Epidemiol.  10-1-2002, 156 (7): 634-640. 
  16. Mixeu, M. A., Vespa, G. N., Forleo-Neto, E., Toniolo-Neto, J., and Alves, P. M.   Impact of Influenza Vaccination on Civilian Aircrew Illness and Absenteeism Aviat.Space Environ.Med.  2002, 73 (9): 876-880. 
  17. O'Reilly, D., Gormley, G., Gilliland, A., Cuene-Grandidier, H., Rafferty, C., Reilly, P., Steele, K., Stevenson, M., and Smyth, B.  Influenza Vaccinations in Northern Ireland: Are Older Patients Missing Out? Age Ageing  2002, 31 (5): 385-390. 
  18. Orr, P.  Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-Respiratory Syndrome in Association With Influenza Vaccination Can.Commun.Dis.Rep.  9-1-2002, 28:1: 1. 
  19. Perez-Trallero, E., Vicente, D., Montes, M., and Cisterna, R.  Positive Effect of Meningococcal C Vaccination on Serogroup Replacement in Neisseria Meningitidis Lancet  9-21-2002, 360 (9337): 953. 
  20. Petousis-Harris, H.  Needle Angle When Giving i.m. Vaccinations Nurs.Prax.N.Z.  2002, 18 (2): 52-53. 
  21. Pfahlberg, A., Botev, I. N., Kolmel, K. F., and Gefeller, O.  Vaccination and Melanoma Risk Int.J.Cancer  11-1-2002, 102 (1): 96-97. 
  22. Pfahlberg, A., Kolmel, K. F., Grange, J. M., Mastrangelo, G., Krone, B., Botev, I. N., Niin, M., Seebacher, C., Lambert, D., Shafir, R., Schneider, D., Kokoschka, E. M., Kleeberg, U. R., Uter, W., and Gefeller, O.  Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study J.Invest Dermatol.  2002, 119 (3): 570-575. 
  23. Rayner, J. O., Dryga, S. A., and Kamrud, K. I.  Alphavirus Vectors and Vaccination Rev.Med.Virol.  2002, 12 (5): 279-296. 
  24. Razum, O.  Editorial: A Farewell to Polio Vaccination? Not Anytime Soon Trop.Med.Int.Health  2002, 7 (10): 811-812. 
  25. Ring, A., Marx, G., Steer, C., and Harper, P.  Influenza Vaccination and Chemotherapy: a Shot in the Dark? Support.Care Cancer  2002, 10 (6): 462-465. 
  26. Roche, P. and Spencer, J.  Polio Eradication in Australia and the World Commun.Dis.Intell.  2002, 26 (2): 113-117. 
  27. Shlush, L. I., Behar, D. M., Zelazny, A., Keller, N., Lupski, J. R., Beaudet, A. L., and Bercovich, D.   Molecular Epidemiological Analysis of the Changing Nature of a Meningococcal Outbreak Following a Vaccination Campaign J.Clin.Microbiol.  2002, 40 (10): 3565-3571. 
  28. Siedler, A., Hermann, M., Schmitt, H. J., and Von Kries, R.  Consequences of Delayed Measles Vaccination in Germany Pediatr.Infect.Dis.J.  2002, 21 (9): 826-830. 
  29. Vazquez, J. A.  [Development of Vaccinations Against Meningococcus: a Long, Winding, and Still Unfinished Road] Enferm.Infecc.Microbiol.Clin.  2002, 20 (7): 313-315. 
  30. Vidyashankar, C.  Optimal Age for Measles Vaccination J.Indian Med.Assoc.  2002, 100 (1): 24-26. 
  31. Yazbak, F. and Yazbak, K.  Live Virus Vaccination Near a Pregnancy: Flawed Policies, Tragic Results Med.Hypotheses  2002, 59 (3): 283.

[top]